PhilipMBrownMDJ.D.
Research • Morrisville, NCClinical Pharmacology
Chief Medical Officer-- Dermavant Sciences
Dr. Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3300 Paramount Parkway
Ste 150
Morrisville, NC 27560Phone+1 817-584-1824
Summary
- Philip Brown, MD, is a healthcare professional based in Dallas, Texas, specializing in pharmaceutical development. He graduated in 1989 from Texas Tech University Health Sciences Center School of Medicine and also holds a J.D. from the University of Texas School of Law. Dr. Brown has contributed to publications including the Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis in the New England Journal of Medicine. He has received the CMS Meaningful Use Stage 1 Certification from eClinicalWorks EHR in 2011-2012.
Education & Training
Texas Tech University Health Sciences Center School of MedicineClass of 1989
University of Texas- school of lawJ.D., Law
Certifications & Licensure
VA State Medical License 1994 - 2020
TX State Medical License 1990 - 2019
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2012
Publications & Presentations
Journal Articles
- Phase 3 Trials of Tapinarof Cream For Plaque PsoriasisLebwohl M., Stein-Gold L, Strober B, Papp K, Armstrong A, Bagel J, Kircik L, Ehst B, Hong CH, Soung J, Fromowitz J, Guenthner S, Piscitelli S, Rubenstein D, Brown PM, ..., N Engl J Med, 12/9/2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
